|
PPP3CA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.151900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.462640E-01 |
| Normal-vs-Stage2 |
6.874200E-01 |
| Normal-vs-Stage3 |
1.901630E-01 |
| Normal-vs-Stage4 |
7.778400E-01 |
| Stage1-vs-Stage2 |
6.946600E-01 |
| Stage1-vs-Stage3 |
6.557000E-01 |
| Stage1-vs-Stage4 |
7.975600E-01 |
| Stage2-vs-Stage3 |
5.161400E-01 |
| Stage2-vs-Stage4 |
9.785600E-01 |
| Stage3-vs-Stage4 |
6.396400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.606300E-02 |
| Normal-vs-AfricanAmerican |
5.033000E-01 |
| Normal-vs-Asian |
6.202500E-02 |
| Caucasian-vs-AfricanAmerican |
3.686400E-01 |
| Caucasian-vs-Asian |
5.579000E-01 |
| AfricanAmerican-vs-Asian |
3.695400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.131900E-02 |
| Normal-vs-Female |
9.821200E-01 |
| Male-vs-Female |
6.856200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.746200E-02 |
| Normal-vs-Extreme_Weight |
1.164750E-01 |
| Normal-vs-Obese |
4.775000E-01 |
| Normal-vs-Extreme_Obese |
6.661600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.668200E-01 |
| Normal_Weight-vs-Obese |
3.244400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.172800E-01 |
| Extreme_Weight-vs-Obese |
4.910400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.696600E-01 |
| Obese-vs-Extreme_Obese |
9.503200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.535200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.491200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.615400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.073980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.071200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.927700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.366790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.313600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.138400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.316000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.197180E-01 |
| Normal-VS-Type2 PRCC |
5.769200E-04 |
| Normal-VS-KIRP CIMP |
4.208800E-01 |
| Normal-VS-Unclassified PRCC |
4.153600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.876100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.645800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.030770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.276490E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.564580E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.620000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.682700E-03 |
| Normal-vs-N1 |
5.353400E-01 |
| Normal-vs-N2 |
9.531000E-01 |
| N0-vs-N1 |
2.617800E-01 |
| N0-vs-N2 |
2.530200E-01 |
| N1-vs-N2 |
7.569000E-01 |
|
|
